Evidence map›Paper›PMID 29466660›Full record

ArticleJournal of the American Chemical Society2018

A Versatile Approach to Noncanonical, Dynamic Covalent Single- and Multi-Loop Peptide Macrocycles for Enhancing Antimicrobial Activity.

James F Reuther, Andrew C Goodrich, P Rogelio Escamilla, Tiffany A Lu, Valarie Del Rio, Bryan W Davies, Eric V Anslyn

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Peptide Macrocyclization Guided by Reversible Covalent Templating.Chemistry (Weinheim an der Bergstrasse, Germany) · 2023
    Article
  3. Review
  4. Article
  5. Dynamic Covalent Polymers for Biomedical Applications.Materials chemistry frontiers · 2020
    Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

James F ReutherDepartment of Chemistry , University of Texas at Austin , Austin , Texas 78712 , United States.ORCID 0000-0001-5611-0290
Andrew C GoodrichLaMontange Center for Infectious Diseases, Department of Molecular Biosciences , University of Texas at Austin , Austin , Texas 78712 , United States.
P Rogelio EscamillaDepartment of Chemistry , University of Texas at Austin , Austin , Texas 78712 , United States.
Tiffany A LuDepartment of Chemistry , University of Texas at Austin , Austin , Texas 78712 , United States.
Valarie Del RioDepartment of Chemistry , University of Texas at Austin , Austin , Texas 78712 , United States.
Bryan W DaviesLaMontange Center for Infectious Diseases, Department of Molecular Biosciences , University of Texas at Austin , Austin , Texas 78712 , United States.
Eric V AnslynDepartment of Chemistry , University of Texas at Austin , Austin , Texas 78712 , United States.ORCID 0000-0002-5137-8797
The University of Texas at Austin · US

Funding

A High-Throughput Molecular Platform for Antimicrobial Discovery and StudyR01AI125337 · NIAID · UNIVERSITY OF TEXAS AT AUSTIN · PI DAVIES, BRYAN WILLIAM · 2016 to 2020
$2.0M
Redox Sensitive Proteins in Aging and NeurodegenerationR01AG025337 · NIA · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI SCHUBERT, DAVID R · 2004 to 2006
$1.2M
NIAID NIH HHS R01 AI125337NIA NIH HHS R01 AG025337
6 · The paper itself

Abstract

Peptide oligomers offer versatile scaffolds for the formation of potent antimicrobial agents due to their high sequence versatility, inherent biocompatibility, and chemical tunability. Though many methods exist for the formation of peptide-based macrocycles (MCs), increasingly pervasive in commercial antimicrobial therapeutics, the introduction of multiple looped structures into a single peptide oligomer remains a significant challenge. Herein, we report the utilization of dynamic hydrazone condensation for the versatile formation of single-, double-, and triple-loop peptide MCs using simple dialdehyde or dihydrazide small-molecule cross-linkers, as confirmed by MALDI-TOF MS, HPLC, and SDS-PAGE. Furthermore, incorporation of aldehyde-containing side chains onto peptides synthesized from hydrazide C-terminal resins resulted in tunable peptide MC assemblies formed directly upon resin cleavage post solid-phase peptide synthesis. Both of these types of dynamic covalent assemblies produced significant enhancements to overall antimicrobial properties when introduced into a known antimicrobial peptide, buforin II, when compared to the original unassembled sequence.

Indexed as

Amino Acid SequenceAnti-Bacterial AgentsBacteriaBacterial InfectionsChemistry Techniques, SyntheticHumansMacrocyclic CompoundsPeptidesProteinsAnti-Bacterial Agentsbuforin IIMacrocyclic CompoundsPeptidesProteins

Identifiers

PMID29466660
PMCPMC5942189
OpenAlexW2788111798

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.